A Noncytolytic IL-10/Fc Fusion Protein Prevents Diabetes, Blocks Autoimmunity, and Promotes Suppressor Phenomena in NOD Mice

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4507-4513

  Zheng, Xin Xiao ^a   Steele, Alan W ^a,b   Hancock, Wayne W ^a   Stevens, A Christopher ^a   Nickerson, Peter W ^a,c   Roy Chaudhury, Prabir ^a,d   Tian, Yan ^a   Strom, Terry B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Basic Medical Sciences Bldg ^*  (Canada)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 10;

ACUTE DISEASE; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CHEMISTRY; FEMALE; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PASSIVE IMMUNIZATION; PATHOLOGY; REGULATORY T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FC FRAGMENTS; INTERLEUKIN-10; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 0031131886     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese diabetic strain of mice. Exp. Animals 29:1.
2. Rossini, A. A., J. P. Mordes, and A. A. Like. 1985. Immunology of insulin-dependent diabetes mellitus. Annu. Rev. Immunol. 3:289.
3. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin 10. Annu. Rev. Immunol. 11:165.
4. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
5. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
6. Hsu, D.-H., K. W. Moore, and H. Spits. 1992. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity. Int. Immunol. 4:563.
7. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferonγ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
8. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibilty complex expression. J. Exp. Med. 174:915.
9. Taga, K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143.
10. Bejarano, M.-T., R. de Waal Malefyt, J. S. Abrams, M. Bigler, R. Bacchetta, J. E. de Vries, and M.-G. Roncarolo. 1992. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte culture. Int. Immunol. 4:1389.
11. Villanueva, P. O. F., S. M. Chikunguwo, T. S. Harris, and M. J. Stadecker. 1993. Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J. Immunol. 151:3192.
12. Villanueva, P. O. F., T. S. Harris, D. E. Ricklan, and M. J. Stadecker. 1994. Macrophages from schistosomal egg granulomas induce unresponsiveness in specific cloned Th-1 lymphocytes in vitro and down-regulate schistosomal granulomatous disease in vivo. J. Immunol. 152:1847.
13. Pennline, K. J., E. Roque-Gaffney, and M. Monahan. 1994. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:169.
14. Chernoff, A. E., E. V. Granowitz, L. Shapiro, E. Vannier, G. Lonnemann, J. B. Angel, J. S. Kennedy, A. R. Rabson, S. M. Wolff, and C. A. Dinarello. 1995. A randomized, controlled trial of IL-10 in human. J. Immunol. 154:5490.
15. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
16. Zheng, X. X., A. W. Steele, P. Nickerson, W. Steurer, J. Steiger, and T. B. Strom. 1995. Administration of non-cytolytic IL-10/Fc in LPS-induced septic shock and allogeneic islet transplantation mutine animal models. J. Immunol. 154:5590.
17. Duncan, A. R., and G. Winter. 1988. The binding site for C1q on IgG. Nature 332:738.
18. Duncan, A. R., J. M. Woof, L. J. Partridge, D. R. Burton, and G. Winter. 1988. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332:563.
19. Flores-Villanueva, P. O., X. X. Zheng, T. B. Strom, and M. J. Stadecker. 1996. Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 156:3315.
20. Hancock, W. W., M. Polanski, J. Zhang, N. Blogg, and H. L. Weiner. 1995. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4, IL-10, TGF-β and prostaglandin-E. Am. J. Pathol. 155:1193.
21. Mottram, P. L., W. R. Han, L. J. Purcell, I. F. C. McKenzie, and W. W. Hancock. 1995. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and IFN-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 59:559.
22. Hancock, W. W., M. H. Sayegh, C. A. Kwok, H. L. Weiner, and C. B. Carpenter. 1993. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 55:219.
23. Bill, J., F. Ronchese, R. N. Germain, and E. Palmer. 1989. The contribution of mutant amino acids to alloantigenicity. J. Exp. Med. 170:739.
24. Ogawa, M., T. Maruyama, T. Hasegawa, T. Kanaya, F. Kobayashi, Y. Tochino, and H. Uda. 1985. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetic (NOD) mice. Biomed. Res. 6:103.
25. Mori, Y., M. Suko, H. Okudaira, I. Matsuba, A. Tsuruoka, A. Sasaki, H. Yokoyama, T. Tanase, T. Shida, M. Nishimura, E. Terada, and Y. Ikeda. 1986. Preventive effects of cyclosporin in diabetes in NOD mice. Diabetologia 29:244.
26. Biotard, C., A. Bendelac, M. F. Richard, C. Carnaud, and J. F. Bach. 1988. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc. Natl. Acad. Sci. USA 85:9719.
27. Shizuru, J. A., C. Taylor-Edwards, B. A. Banks, A. K. Gregory, and C. G. Fathman. 1988. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240:659.
28. Kelley, V. K., O. Bacha, J. C. Nichols, J. R. Murphy, and T. B. Strom. 1988. Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo. Proc. Natl. Acad. Sci. USA 85:3980.
29. Wicker, L. S., B. J. Miller, and Y. Mullen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:815.
30. Bendelac, A., C. Carnaud, C. Biotard, and J. F. Bach. 1987. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J. Exp. Med. 166:823.
31. Lee, K. U., K. Amano, and J. W. Yoon. 1988. Evidence for initial involvement of macrophage subpopulations in pancreas of prediabetic BB/E rats. Diabetes 37:989.
32. Lee, K. U., M. K. Kim, K. Amano, C. Y. Pak, M. A. Jaworski, J. G. Mehta, and J. W. Yoon. 1988. Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rat. Diabetes 37:1053.
33. Charlton, B., A. Bacelj, and T. E. Mandel. 1988. Administration of silica paticles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37:930.
34. Oschilewski, O., U. Kiesel, and H. Kolb. 1985. Administration of silica prevents diabetes in BB-rats. Diabetes 34:197.
35. Rott, O., B. Fleischer, and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434.
36. Huitinga, I., N. van Rooijen, C. J. A. de Groot, and B. M. Uitdehaag. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1025.
37. Brosnan, C. F., M. B. Bornstein, and B. R. Bloom. 1981. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:614.
38. Pankewycz, O., T. B. Strom, and V. E. Rubin-Kelley. 1991. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset of diabetes. Eur J. Immunol. 21:873.
39. Lee, M.-S., R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663.
40. Diaz-Gallo, C., M. Moscovitch-Lopatin, T. B. Strom, and V. Rubin Kelly. 1992. An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes, secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation. Proc. Natl. Acad. Sci. USA 89:8656.
41. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 182:87.